Who owns Ernexa Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of ERNAW from SEC Form 13F filings across 6 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 6 institutions disclosed 2.8M shares of Ernexa Therapeutics Inc. worth $202,265 — about 239.8% of shares outstanding; the largest disclosed holder is Bleichroeder LP. Source: SEC Form 13F filings, parsed by EvidInvest.
6
13F holders
$202,265
value, 2026 filers
239.8%
of shares outstanding (2.8M sh)
1
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of ERNAW's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Bleichroeder LP | 2.0M | $142,600 | 0.0% | 169.1% | 0.0% |
| 2 | HEIGHTS CAPITAL MANAGEMENT, INC | 400,000 | $28,520 | 0.0% | 33.8% | 0.0% |
| 3 | ARMISTICE CAPITAL, LLC | 160,000 | $11,408 | 0.0% | 13.5% | -96.0% |
| 4 | Clear Street Group Inc. | 149,499 | $10,659 | 0.0% | 12.6% | +0.1% |
| 5 | Warberg Asset Management LLC | 69,430 | $4,950 | 0.0% | 5.9% | -72.6% |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 57,890 | $4,128 | 0.0% | 4.9% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.